Wanze Co., Ltd.: The total guarantee amount for the company and its subsidiaries reaches 1.915 billion yuan

NightAirdropper · 2026-02-27T15:43:49+00:00

Wanze Co., Ltd. provides guarantees for its subsidiary Wanze Aviation, with a limit of 50 million yuan, and a guarantee balance of 1.87 billion yuan. The company's asset-liability ratio is relatively high, reaching 60.97% in 2024. Wanze Co., Ltd. mainly focuses on micro-ecological products, and its operating income has continued to grow in recent years.

NightAirdropper

2026-02-27 15:43:49

Abstract generation in progress

Radar Finance | Text by Yang Yang | Edited by Li Yihui

On February 26, Wanze Co., Ltd. (Stock Code: 000534) announced that it provided guarantees for its subsidiary, Shenzhen Wanze Aviation Technology Co., Ltd. Wanze Aviation has obtained a 50 million yuan Shenzhen Intellectual Property ABS loan from Shenzhen High-tech Investment Small Loan Co., Ltd., with a one-year term, for daily operational turnover. The credit line is jointly guaranteed by the company, Inner Mongolia Shuangqi Pharmaceutical Co., Ltd., and Mr. Lin Weiguang, the company’s actual controller, with a guarantee liability. Additionally, two patents owned by Wanze Aviation are used as collateral.

After providing the guarantee, the company’s guarantee balance for Wanze Aviation is 187.3757 million yuan. Wanze Aviation’s most recent unaudited total assets amount to 480.192 million yuan, total liabilities are 362.9875 million yuan, and net profit is -6.9056 million yuan. The total guarantee amount for the company and its controlling subsidiaries is 5.6 billion yuan, with a total guarantee balance of 1.9153984 billion yuan, accounting for 140.74% of the company’s audited net assets in 2024.

According to Tianyancha, Wanze Co., Ltd. was established on November 4, 1992, with a registered capital of approximately 500.7081 million yuan. The legal representative is Lin Weiguang, and the registered address is 8th Floor, Building B, Guangming Building, No. 23 Zhuchi Road, Shantou. The main business includes the research, development, manufacturing, and sales of micro-ecological active bacteria products, high-temperature alloys, and their derivatives.

Currently, the company’s chairman is Lin Weiguang, the secretary is Cai Yongfeng, with 1,397 employees, and the actual controller is Lin Weiguang.

The company has 19 associated companies, including Zhuhai Wanze Biopharmaceutical Co., Ltd., Shenzhen Subair Aviation Materials Co., Ltd., Shenzhen Wanze Precision Casting Technology Co., Ltd., Shenzhen Wanze Aviation Technology Co., Ltd., Inner Mongolia Shuangqi Biotechnology Co., Ltd., and others.

In terms of performance, the operating revenues for 2022, 2023, and 2024 are approximately 794 million yuan, 981 million yuan, and 1.079 billion yuan, respectively, with year-on-year growth rates of 20.97%, 23.63%, and 9.93%. Net profits attributable to the parent company are approximately 102 million yuan, 177 million yuan, and 193 million yuan, with year-on-year growth rates of 6.74%, 73.54%, and 9.17%. During the same period, the company’s asset-liability ratios are 49.06%, 58.19%, and 60.97%.

Regarding risks, Tianyancha data shows the company has 416 internal Tianyan risks, 103 surrounding risks, 17 historical risks, and 218 warning alert risks.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.